American clinical laboratory 1995-07-01

Development of a method for the analysis of warfarin and metabolites in plasma and urine.

J X de Vries, E Schmitz-Kummer

文献索引：Am. Clin. Lab. 14(7) , 20-1, (1995)

结构式	名称/CAS号	分子式	全部文献
	6-羟基华法林 CAS:17834-02-5	C₁₉H₁₆O₅
	7-羟基华法林 CAS:17834-03-6	C₁₉H₁₆O₅

Investigation of two-dimensional high performance liquid chr...
2014-10-10
[J. Chromatogr. A. 1363 , 200-6, (2014)]

Hydroxywarfarin metabolites potently inhibit CYP2C9 metaboli...
2010-05-17
[Chem. Res. Toxicol. 23(5) , 939-45, (2010)]

Metabolism of R- and S-warfarin by CYP2C19 into four hydroxy...
2012-09-01
[Drug Metab. Lett. 6(3) , 157-64, (2012)]

Warfarin is an effective modifier of multiple UDP-glucuronos...
2015-01-01
[J. Pharm. Sci. 104(1) , 244-56, (2014)]

Analysis of R- and S-hydroxywarfarin glucuronidation catalyz...
2012-01-01
[J. Pharmacol. Exp. Ther. 340(1) , 46-55, (2012)]